A Phase I/II Open-label Study of MCS110 in Patients With Prostate Cancer and Bone Metastases

This study has been terminated.

( Novartis decided to terminate based on strategic and administrative reasons. )

Study NCT00757757 Information provided by Novartis

First Received: September 21, 2008 Last Updated: November 10, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	No date given
Primary Completion Date:	August 2009 (Final data collection date for primary outcome measure)